Ethics. Research. Community.

Blogging Ethics

Note: blog content is not currently included in EthicShare's Search Results.

10/18/2017 - 11:04pm
Soon I will post about the passing of my colleague, science fiction author and unique American Jerry Pournelle. And of course much of what I post about today will be altered after we see what is wrought by Hurricanes Irma, José and Katia.  But this series conclusion is already prepared.
10/18/2017 - 3:55pm

by Craig Klugman, Ph.D.

We have come to that magical time of year again when academic and professional organizations hold their annual meetings. Thousands of educators, researchers, and scholars fly from all over the country (and the world) to descend upon one city. They will spend 2-5 days giving and listening to talks, networking, learning about new opportunities, meeting with publishers and potential employers, and advancing conversations in their field. Most faculty members’ jobs have expectations that they will attend and contribute to these conferences.…

10/18/2017 - 11:05am

Our handy guide to everything Johns Hopkins Berman Institute of Bioethics at the 19th annual meeting of the American Society for Bioethics + Humanities (ASBH). Join us in Kansas City, October 19 - 22, 2017

10/18/2017 - 11:01am

Researchers at the University of Maryland School of Medicine were shocked to find that nearly half of all medical care in the United States is delivered at hospital emergency departments

10/18/2017 - 10:58am

After a Marine attacked an Iraqi restaurant in Portland, Ore., his family said he was provoked by trauma, not hate, and that he needed help, not jail time

10/18/2017 - 10:50am

Bizarre as this seems, researchers have seen hints of a “mother effect” on blood transfusions before. Half a dozen studies have found that recipients were more likely to die after receiving blood from a woman than from a man — though the biggest and most recent did not

10/17/2017 - 3:53pm

Adam Gaffney and our Zackary Berger write, "Single payer bills signal a new era in American healthcare politics"

10/17/2017 - 10:30am

But while at first glance the global trend lines still look promising, Vos says a closer look at the statistics reveal stubborn problems that threaten that rosy picture. Increasingly this year, he says, cracks are starting to show

10/17/2017 - 9:50am

Total costs of Kymriah and the 21 similar drugs in development — known as CAR T-cell therapies — will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.

10/17/2017 - 9:39am

A federal judge in Texas invalidated four key patents for the dry-eye treatment Restasis on Monday, dealing a blow to its manufacturer, Allergan, which had sought to protect its patents by transferring them to a Native American tribe